BiotechTube
Home/Refoxy Pharmaceuticals/Dorottya Keppel
DK

Dorottya Keppel

Director of Drug Discovery

Refoxy Pharmaceuticals

Therapeutic Areas

Idiopathic Pulmonary FibrosisFibrotic DiseasesCardiovascular DiseasesAge-Related Diseases

Refoxy Pharmaceuticals Pipeline

DrugIndicationPhase
FOXO3 Modulator ProgramIdiopathic Pulmonary Fibrosis (IPF) / Fibrotic DiseasesPre-clinical

Leadership Team at Refoxy Pharmaceuticals

DV
Dr. Victor Bustos
Co-founder & CEO
PW
Prof. Wolfgang Link
Scientific Co-founder & Advisor
BG
Björn Geigle
Director of Bioinformatics
SN
Sarah Nielsen
Executive Assistant
View full Refoxy Pharmaceuticals profile